Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
This study is investigating if a different blood-thinning medicine, clopidogrel, could be more helpful than aspirin for people who have a serious blood infection caused by Staphylococcus aureus bacteria. This type of infection is often called S. aureus bacteremia. We are focusing on patients who already take aspirin to prevent heart attacks or strokes. We want to see if switching to clopidogrel, which might have an effect against the bacteria itself, can improve how well people recover from the infection. This is part of a larger ongoing study and could help us understand better ways to treat S. aureus infections in the future.
At a glance
What is this study about?
You might be familiar with aspirin as a medicine that helps prevent heart attacks and strokes. There's another similar medicine called clopidogrel that does a similar job. This study is looking into whether clopidogrel could offer an extra benefit for people who have a particular type of blood infection caused by a germ called Staphylococcus aureus, often shortened to S. aureus.
The S. aureus infection can be quite serious, sometimes leading to heart valve infections (endocarditis) or spreading through the bloodstream (septicaemia). We know both aspirin and clopidogrel thin the blood, and that's why people take them to protect their heart and circulation. But some early research suggests clopidogrel might also have an effect that helps fight off the S. aureus germ itself, which aspirin doesn't.
So, for people who are already taking aspirin because of their heart or circulation health, this study wants to find out if switching from aspirin to clopidogrel could improve their recovery from an S. aureus blood infection. The aim is to see if this common medicine could do 'double duty' – protecting the heart and helping to fight the infection at the same time.
Key takeaways
- Compares aspirin to clopidogrel for S. aureus blood infections.
- People already taking aspirin for heart/circulation problems are included.
- Aims to see if clopidogrel has an added anti-infection benefit.
- Participation involves taking one of the two medicines and being monitored.
- Part of a larger research effort to improve treatments.
- You can stop participating at any time.
Who may be eligible?
To take part in this study, you need to be an adult over 18 years old. You must also already be taking aspirin to help prevent future heart problems, strokes, or issues with blood flow to your legs or other areas where blood vessels might be narrow.
However, you cannot join if you are currently bleeding a lot, or if you are expected to have a major surgery (like heart, brain, or spine surgery) within the next three days. You also can't participate if you are pregnant, or if you have recently taken other medicines similar to clopidogrel within the last month. If you are allergic to clopidogrel, or if you are taking a specific type of blood thinner called an oral Xa inhibitor, you would also not be able to join this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you currently taking aspirin to prevent heart attacks or strokes?
- Do you have a Staphylococcus aureus (S. aureus) blood infection?
- Are you not currently bleeding a lot or due for major surgery very soon?
- Are you not pregnant?
- Have you not taken clopidogrel or similar medicines in the last month?
What does participation involve?
If you are eligible and agree to take part, you will be randomly assigned to either continue taking your usual aspirin or switch to clopidogrel. This is like flipping a coin, so it's a fair way to compare the two medicines. You would take the assigned medication as directed. The study would involve regular check-ups and monitoring of your health, similar to what you might already have when being treated for your S. aureus infection. We would follow your progress to see how you recover. The total duration of your participation would depend on your recovery from the infection, but generally, it would involve continuing the assigned medication for a period and then monitoring your health outcomes.
Potential risks and benefits
Locations (1)
- McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital)Verified postcodeMontreal, Canada· Recruiting
Common questions
What is S. aureus bacteremia?
It's a serious blood infection caused by a common type of bacteria called Staphylococcus aureus.
What's the main goal of this study?
To see if switching from aspirin to clopidogrel improves recovery for people with S. aureus blood infections who already take aspirin for other health issues.
Will I definitely get clopidogrel if I join?
No, you'll be randomly assigned to either continue aspirin or switch to clopidogrel, like drawing lots.
Are there any side effects?
Both aspirin and clopidogrel can increase the risk of bleeding, and your doctors will watch you carefully for this.
Can I leave the study if I change my mind?
Yes, you can choose to stop participating at any time, and it won't affect your regular medical care.
How to find out more
Lina Petrella
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.